Cindy Reiss-Clark - 22 Aug 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Chief Commercial Officer
Signature
/s/ Cynthia Reiss-Clark
Issuer symbol
WST
Transactions as of
22 Aug 2023
Net transactions value
-$1,820,279
Form type
4
Filing time
24 Aug 2023, 19:24:48 UTC
Previous filing
23 Feb 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $192,621 +1,112 +26% $173.22 5,432 22 Aug 2023 Direct
transaction WST Common Stock Options Exercise $435,573 +1,588 +29% $274.29 7,020 22 Aug 2023 Direct
transaction WST Common Stock Options Exercise $286,814 +777 +11% $369.13 7,797 22 Aug 2023 Direct
transaction WST Common Stock Sale $1,367,643 -3,477 -45% $393.34 4,320 22 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to buy) Options Exercise $305,625 -777 -25% $393.34 2,331 22 Aug 2023 Common Stock 777 $369.13 Direct F1
transaction WST Stock Options (Right to buy) Options Exercise $624,624 -1,588 -50% $393.34 1,588 22 Aug 2023 Common Stock 1,588 $274.29 Direct F2
transaction WST Stock Options (Right to buy) Options Exercise $437,394 -1,112 -39% $393.34 1,756 22 Aug 2023 Common Stock 1,112 $173.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal annual installments beginning on February 22, 2023.
F2 This award vests in four equal annual installments beginning on February 23, 2022.
F3 This award vests in four equal annual installments beginning on February 18, 2021.